Ausgabe 2/2021
Inhalt (30 Artikel)
Breast cancer patients with a negative axillary ultrasound may have clinically significant nodal metastasis
Stephen Keelan, Anna Heeney, Eithne Downey, Aisling Hegarty, Trudi Roche, Colm Power, Neasa Ni Mhuircheartaigh, Deirdre Duke, Jennifer Kerr, Niamh Hambly, Arnold Hill
New horizons in imaging and surgical assessment of breast cancer lymph node metastasis
Firouzeh Arjmandi, Ann Mootz, Deborah Farr, Sangeetha Reddy, Basak Dogan
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
D. Trapani, F. Giugliano, J. Uliano, V. A. A. Zia, A. Marra, G. Viale, E. Ferraro, A. Esposito, C. Criscitiello, P. D’amico, G. Curigliano
SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breast
Julia Y. Tsang, Sui-Ting Lai, Yun-Bi Ni, Yan Shao, Ivan K. Poon, Johnny S. Kwan, Chit Chow, Ka-Ho Shea, Gary M. Tse
NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis
Mengting Chen, Yang Zhao, Xueli Yang, Yuanyuan Zhao, Qiqi Liu, Yang Liu, Yifeng Hou, Hefen Sun, Wei Jin
Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer
Anjana Bhardwaj, Matthew D. Embury, Raniv D. Rojo, Constance Albarracin, Isabelle Bedrosian
FASN inhibition as a potential treatment for endocrine-resistant breast cancer
Aleksandra Gruslova, Bryan McClellan, Henriette U. Balinda, Suryavathi Viswanadhapalli, Victoria Alers, Gangadhara R. Sareddy, Tim Huang, Michael Garcia, Linda deGraffenried, Ratna K. Vadlamudi, Andrew J. Brenner
Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
Neelima Vidula, Christina Yau, Hope S. Rugo
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer
Ami N. Shah, Kristen J. Carroll, Lorenzo Gerratana, Chenyu Lin, Andrew A. Davis, Qiang Zhang, Saya Jacob, Brian Finkelman, Youbin Zhang, Wenen Qiang, Paolo D’Amico, Carolina Reduzzi, William J. Gradishar, Amir Behdad, Massimo Cristofanilli
The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer
Adriana M. Coletta, Nadia H. Agha, Forrest L. Baker, Grace M. Niemiro, Preteesh L. Mylabathula, Abenaa M. Brewster, Therese B. Bevers, Enrique Fuentes-Mattei, Karen Basen-Engquist, Susan C. Gilchrist, Richard J. Simpson
A propensity score-matched comparison of recurrence outcomes after immediate implant vs autologous flap reconstruction in patients receiving neoadjuvant chemotherapy for breast cancer
Zhen-Yu Wu, Hyun Ho Han, Hee Jeong Kim, Jong Won Lee, Il Yong Chung, Jisun Kim, Sae Byul Lee, Byung-Ho Son, Jin Sup Eom, Jae Ho Jung, Sung- Bae Kim, Gyungyub Gong, Hak Hee Kim, Sei -Hyun Ahn, BeomSeok Ko
Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors
Michelle Peate, Christobel Saunders, Paul Cohen, Martha Hickey
The impact of age on patient-reported outcomes after oncoplastic versus conventional breast cancer surgery
M. Ritter, B. M. Ling, I. Oberhauser, G. Montagna, L. Zehnpfennig, J. Lévy, S. D. Soysal, L. López Castrezana, M. Müller, F. D. Schwab, C. Kurzeder, M. Haug, W. P. Weber, E. A. Kappos
Prognostic value of p53 expression in hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients receiving neoadjuvant chemotherapy
Loai Saleh Albinsaad, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Sei-Hyun Ahn, Sae Byul Lee
Direct comparison of three different mathematical models in two independent datasets of EUSOMA certified centers to predict recurrence and survival in estrogen receptor-positive breast cancer: impact on clinical practice
Cristiana Iacuzzo, Fabiola Giudici, Serena Scomersi, Rita Ceccherini, Fabrizio Zanconati, Daniele Generali, Marina Bortul
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study
Sherko Kuemmel, Carlo A. Tondini, Jacinta Abraham, Zbigniew Nowecki, Bartosz Itrych, Erika Hitre, Bogusława Karaszewska, Alejandro Juárez-Ramiro, Flavia Morales-Vásquez, Jose Manuel Pérez-García, Servando Cardona-Huerta, Estefania Monturus, Marco Sequi, Eleonora Restuccia, Mark Benyunes, Miguel Martín
Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
Sharon McGee, Mashari Alzahrani, Lisa Vandermeer, Katherine Cole, Gail Larocque, Arif Awan, Brian Hutton, Gregory Pond, Deanna Saunders, Mark Clemons
Examining the effect of obesity-associated gene variants on breast cancer survivors in a randomized weight loss intervention
ThaiHien Nguyen, Melinda L. Irwin, Andrew T. Dewan, Brenda Cartmel, Maura Harrigan, Leah M. Ferrucci, Tara Sanft, Fangyong Li, Lingeng Lu, Yasmmyn D. Salinas
Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands
Coco J. E. F. Walstra, Robert-Jan Schipper, Yvonne E. van Riet, Peter-Paul G. van der Toorn, Marjolein L. Smidt, Maurice J. C. vd Sangen, Adri C. Voogd, Grard A. P. Nieuwenhuijzen
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers
Neda Stjepanovic, Jan Lubinski, Pal Moller, Susan Randall Armel, William D. Foulkes, Nadine Tung, Susan L. Neuhausen, Joanne Kotsopoulos, Ping Sun, Sophie Sun, Andrea Eisen, Steven A. Narod, Leigha Senter, Charis Eng Fergus Couch, Robert Fruscio, Jeffrey N. Weitzel, Olufunmilayo Olopade, Christian F. Singer, Tuya Pal, Tomasz Huzarski, Cezary Cybulski, Kevin Sweet, Dana Zakalik, Marie Wood, Wendy McKinnon, Christine Elser, Georgia Wiesner, Eitan Friedman, Wendy Meschino, Carrie Snyder, Kelly Metcalfe, Aletta Poll, Ellen Warner, Raymond Kim, Rochelle Demsky, Peter Ainsworth, Linda Steele, Howard Saal, Kim Serfas, Seema Panchal, Carey A. Cullinane, Robert E. Reilly, Joanne L. Blum, Ava Kwong, Daniel Rayson, Teresa Ramón y Cajal, Jeffrey Dungan, Rinat Yerushalmi, Ophira Ginsburg, Intan Schraeder, Stephanie Cohen, Edmond LemireLemire, Stefania Zovato, Antonella Rastelli, Jacek Gronwald, Jeanna McCuaig, Beth Karlan, Louise Bordeleau
Early postoperative outcomes in implant, pedicled, and free flap reconstruction for breast cancer: an analysis of 23,834 patients from the ACS-NSQIP datasets
Murad J. Karadsheh, Richard Tyrell, Mengying Deng, Brian L. Egleston, James C. Krupp, M. Shuja Shafqat, Sameer A. Patel
Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade
Roberto Lo Gullo, Kerri Vincenti, Carolina Rossi Saccarelli, Peter Gibbs, Michael J. Fox, Isaac Daimiel, Danny F. Martinez, Maxine S. Jochelson, Elizabeth A. Morris, Jeffrey S. Reiner, Katja Pinker
Comparison of the performance of four staging systems in determining the prognosis of breast cancer among women undergoing neoadjuvant chemotherapy
Isabella Cristina Santos Soares, Marcelo Adeodato Bello, Anke Bergmann, Luiz Claudio Santos Thuler
Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018
Rajesh Sharma
Exploring provider- and practice-level drivers of cost-consciousness in breast cancer reconstruction—secondary analysis of a survey of the American Society of Plastic Surgeons
Clifford C. Sheckter, Oluseyi Aliu, Chad Bailey, Jun Liu, Jesse C. Selber, Charles E. Butler, Anaeze C. Offodile II
The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
C. van Dooijeweert, I. O. Baas, I. A. G. Deckers, S. Siesling, P. J. van Diest, E. van der Wall
Allostatic score and its associations with demographics, healthy behaviors, tumor characteristics, and mitochondrial DNA among breast cancer patients
Hua Zhao, Renduo Song, Yuanqing Ye, Wong-Ho Chow, Jie Shen
Shall patients’ anxiety influence surgical decisions for atypical breast lesions? A substudy of the prospective NOMAT trial
Flore Salviat, Cécile Charles, Catherine Uzan
Letter to the editor regarding: ‘Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire’
Benjamin Patel, Louise Merker, Ajay Sahu
Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine
Shayma Kazmi, Debanjana Chatterjee, Dheeraj Raju, Rob Hauser, Peter A. Kaufman